You are here


MSF - Response to the World Health Organization's Ebola Road Map


An MSF staff member at the Ebola treatment center in Monrovia, Liberia.  Caroline Van Nespen/MSF - August 28, 2014

Statement from MSF Director of Operations Brice de le Vingne.

“The WHO road map is welcome, but it should not give a false sense of hope. A plan needs to be acted upon. Huge questions remain about who will implement the elements in the plan. Who has the correct training for the variety of tasks that are detailed? How long will it take to train organizations to set up and run an Ebola management center? How long before any new centers become operational? Who will undertake the vitally important health education, contact tracing, and safe burials in the affected communities?

WHO - Ebola Response Roadmap

Publication details

Number of pages: 27
Publication date: August 2014
Languages: English




WHO issued this roadmap for scaled-up response to the Ebola outbreak. The goal is to stop Ebola transmission in affected countries within 6-9 months and prevent international spread.

The roadmap will assist governments and partners in the revision and resourcing of country-specific operational plans for Ebola response, and the coordination of international support for their full implementation. The objectives are:

Experimental Ebola Drug Halts Virus in Monkeys Five Days After They Were Infected

CLICK HERE - RESEARCH - Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp - by Lenny Bernstein - August 29, 2014

The experimental drug pressed into emergency use in the West African Ebola epidemic cured a group of 18 monkeys of the deadly disease, including some who didn't receive the treatment until five days after they were injected with the virus, researchers reported Friday.

The finding, published online in the journal Nature, raises new hope for use of the cocktail of monoclonal antibodies, called ZMapp, against Ebola, which has no known cure or vaccine. . .

. . . "The highlight of these experimental results is undoubtedly ZMapp, which was able to reverse severe [Ebola] disease...leading to full recovery of all treated [non-human primates]" within 28 days after they were infected, the researchers wrote.


Doctors and Nurses Risk Everything to Fight Ebola in West Africa


Craig Kenzie, Junko Otaki, and Luca Zaliani are among the 57 international health care workers assisting with Ebola treatment at a Médecins Sans Frontières facility in Kailahun, Sierra Leone.  Photographs by Samuel Aranda

Foreign and local caregivers are essential to stopping the virus’s deadly spread. - by Karen Weintraub - August 29, 2014

In two Land Rovers, one fitted out as an ambulance, a small team of humanitarian workers last week headed deep into Sierra Leone's jungle. After hours on deeply rutted paths that could barely be called roads, they stopped at a village that had seen ten reported cases of Ebola.

With the consent of the village chief, the team fanned out across the community, asking at each hut if anyone was feeling ill or had made contact with the earlier patients.



US to Test Ebola Vaccine in Humans Amid Growing Outbreak in West Africa


An undated photo from National Institute of Allergy and Infectious Diseases and GlaxoSmithKline shows a vaccine candidate that will be used in the upcoming human trials.  NIAID/GSK/AP Photo - by Katie Moisse - August 28, 2014

U.S. scientists will begin testing an Ebola vaccine in humans next week, health officials announced today. But it could take 11 months to learn whether the vaccine is safe as the virus’ toll in West Africa continues to rise. . .

. . . The experimental vaccine, co-developed by the National Institutes of Health and GlaxoSmithKline, “performed extremely well in protecting nonhuman primates from Ebola infection,” Dr. Anthony Fauci, director of the NIH’s infectious disease branch, said.

Ebola Virus Mutating Rapidly as it Spreads

Outbreak likely originated with a single animal-to-human transmission. - Erika Check Hayden - August 28, 2014

Augustine Goba and his colleagues have now decoded the genetic sequences of 99 Ebola viruses collected from 78 patients during the first 24 days of the epidemic in Sierra Leone. The work, published online in Science, could help to inform the design of diagnostics, therapeutics and vaccines, says structural biologist Erica Ollmann Saphire of The Scripps Research Institute in La Jolla, California. “This paper is terrific,” she adds.


First case of Ebola confirmed in Senegal - health minister

DAKAR Aug 29 (Reuters) - The first case of Ebola has been confirmed in Senegal, a major hub for the business and aid community in West Africa, Health Minister Awa Marie Coll Seck told a news conference on Friday.

The minister said the case was a Guinean national who had arrived from the neighbouring West African country, where the deadly virus was first detected in March.

Reporting by Diadie Ba; Writing by Daniel Flynn; Editing by Emma Farge.


Ebola spreads to Nigeria oil hub Port Harcourt

28 August 2014


Nigeria has confirmed its first Ebola death outside Lagos – a doctor in the oil hub of Port Harcourt.

His wife has been put under quarantine, while a further 70 people in the city are under surveillance.

Latest figures show more than 1,550 people have died of Ebola, with at least 3,000 confirmed cases - mostly in Guinea, Liberia and Sierra Leone.

The World Health Organization (WHO) estimates that the total number of cases could potentially exceed 20,000.

Cell-Phone Data Might Help Predict Ebola’s Spread

On the move: This model of West African regional transportation patterns was built using, among other sources, mobile-phone data for Senegal, released by the mobile carrier Orange.

Mobility data from an African mobile-phone carrier could help researchers recommend where to focus health-care efforts.

By David Talbot on August 22, 2014

Ebola outbreak 'could top 20,000'

Published on Aug. 28, 2014

An outbreak of the Ebola virus in West Africa could amount to 20,000 cases, the World Health organisation says (Centres for Disease Control and Prevention/PA) 



Subscribe to Contagion
howdy folks